Cyclic protein tyrosine kinase inhibitors

US9382219B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Jagabandhu Das · Mercerville, US
• Ramesh Padmanabha · Hamden, US
• Ping Chen · San Diego, US
• Derek J. Norris · Pennington, US
• Arthur M. P. Doweyko · Long Valley, US
• Joel C. Barrish · Richboro, US
• John Wityak · Carlsbad, US

Key dates

• Filing date: Feb 12, 2015
• Grant date: Jul 5, 2016
• Expiry date: Feb 12, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/113
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.